LADENBURG THALMANN FINANCIAL SERVICES INC. - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$0500.0%0.00%
Q2 2016$0500.0%0.00%
Q1 2016$0
-100.0%
50
-76.3%
0.00%
Q4 2015$1,000
-83.3%
211
-88.6%
0.00%
Q3 2015$6,000
-81.8%
1,846
-67.3%
0.00%
-100.0%
Q2 2015$33,000
+65.0%
5,646
+205.9%
0.00%
Q1 2015$20,000
-16.7%
1,846
-29.4%
0.00%
-100.0%
Q4 2014$24,000
+2300.0%
2,616
+2367.9%
0.00%
Q3 2014$1,0000.0%1060.0%0.00%
Q2 2014$1,0000.0%1060.0%0.00%
Q1 2014$1,0001060.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders